Bone Biologics Corp — Director's Dealing 2021

Oct 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bone Biologics Corp (BBLG)
CIK: 0001419554
Period of Report: 2021-10-15

Reporting Person: Hankey Don (Director, Chairman of the Board, 10% Owner)
Reporting Person: HANKEY CAPITAL, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-15	Common Stock	C	5928774	$2.50	Acquired	16915624	Indirect
2021-10-15	Common Stock	C	9361702	—	Disposed	7553922	Indirect
2021-10-15	Common Stock	I	476190	$5.24	Acquired	8030112	Indirect
2021-10-15	Common Stock	G	1004310	—	Disposed	7025802	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-15	Warrants to Purchase Common Stock	$6.30	I	476190	Acquired	2026-10-13	Common (476190)	Indirect

Footnotes

F1: Represents shares issued upon conversion of debt at a conversion rate of $2.50 per share.

F2: Represents cancelation of collateral shares issued to secure the debt.

F3: Represents shares purchased in the Issuer's public offering of units, with each unit consisting of one share of Common Stock and one Warrant. The allocation of a unit is $5.24 for a common share, and $0.01 for a warrant.

F4: Represents shares gifted to third parties.